

浏览全部资源
扫码关注微信
1.广州中医药大学 第一附属医院,广州 510405
2.广州中医药大学 针灸康复临床医学院,广州 510405
3.广州中医药大学 第一临床医学院,广州 510405
Received:31 December 2019,
Published Online:23 July 2020,
Published:20 December 2020
移动端阅览
陆慧敏,孙文熙,霍晨星等.基于MEKK1/SEK1/JNK1/AP-1通路探讨三七总皂苷对4T1乳腺癌荷瘤小鼠肿瘤模型的影响[J].中国实验方剂学杂志,2020,26(24):75-81.
LU Hui-min,SUN Wen-xi,HUO Chen-xing,et al.Effect of Panax Notoginseng Saponins on Breast Cancer Cell Line 4T1 in Tumor-bearing Mice Through MEKK1/SEK1/JNK1/AP-1 Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(24):75-81.
陆慧敏,孙文熙,霍晨星等.基于MEKK1/SEK1/JNK1/AP-1通路探讨三七总皂苷对4T1乳腺癌荷瘤小鼠肿瘤模型的影响[J].中国实验方剂学杂志,2020,26(24):75-81. DOI: 10.13422/j.cnki.syfjx.20201966.
LU Hui-min,SUN Wen-xi,HUO Chen-xing,et al.Effect of Panax Notoginseng Saponins on Breast Cancer Cell Line 4T1 in Tumor-bearing Mice Through MEKK1/SEK1/JNK1/AP-1 Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(24):75-81. DOI: 10.13422/j.cnki.syfjx.20201966.
目的
2
通过研究三七总皂苷对4T1乳腺癌荷瘤小鼠促分裂原激活的蛋白激酶的激酶1(MEKK1)/应激激活的蛋白激酶/细胞外信号调节的蛋白激酶(SAPK/Erk激酶,SEK1)/c-Jun氨基末端激酶1(JNK1)/激活蛋白-1(AP-1)通路的影响,探讨三七总皂苷抑制肿瘤的可能机制。
方法
2
建立4T1乳腺癌荷瘤小鼠肿瘤模型,将48只造模成功的小鼠随机分为三七总皂苷低、中、高剂量组(10,20,40 mg
·
kg
-1
)和模型组,每组12只,三七总皂苷各剂量组腹腔注射剂量为10 mL
·
kg
-1
,模型组给予相同剂量的生理盐水,连续给药28 d。给药结束后分离肿瘤组织、称质量、切片、匀浆等,采用脱氧核苷酸末端转移酶(TdT)介导的dUTP缺口末端标记法(TUNEL)染色检测肿瘤细胞凋亡;实时荧光定量聚合酶链式反应(Real-time PCR)检测肿瘤组织MEKK1,SEK1,JNK1,AP-1 mRNA表达;蛋白免疫印迹法(Western blot)检测4T1乳腺癌荷瘤小鼠肿瘤组织MEKK1,SEK1,JNK1,AP-1蛋白表达。
结果
2
与模型组比较,三七总皂苷中、高剂量组的肿瘤质量明显下降(
P
<
0.05);肿瘤细胞凋亡数量随三七总皂苷剂量的升高明显升高(
P
<
0.05);三七总皂苷中、高剂量组肿瘤组织中MEKK1,SEK1,JNK1,AP-1 mRNA和蛋白表达明显升高(
P
<
0.05)。
结论
2
三七总皂苷对4T1乳腺癌荷瘤小鼠肿瘤模型具有抑制作用,其作用机制可能与激活MEKK1/SEK1/JNK1/AP-1信号通路有关。
Objective
2
To explore the potential mechanisms of Panax Notoginseng Saponins (PNS) on growth inhibition of breast cancer cell line 4T1 in tumor-bearing mice by investigating the mitogen-activated protein kinase kinase kinase 1 (MEKK1)/stress activated protein kinase (SAPK)/extracellular regulated protein kinases (Erk) Kinase (SEK1)/c-Jun
N
-terminal kinase 1 (JNK1)/activator protein-1 (AP-1) signaling pathways.
Method
2
The 4T1 breast cancer mice model was established. Forty-eight mice with successful modeled and randomly divided into the low, medium and high-dose PNS groups (10, 20, 40 mg
·
kg
-1
) and the model control group (12 mice in each group). The PNS groups received intraperitoneal injection with dosage of 10 mL
·
kg
-1
, while the controlled group was given the same dosage of saline. After administration with PNS for 28 days, tumor tissues were isolated, weighed, sliced and homogenized. Tumor cell apoptosis was detected by TdT mediated-dUTP nick end labeling (TUNEL) staining. The mRNA expressions of MEKK1, SEK1, JNK1 and AP-1 in tumor tissue were detected by Real-time polymerase chain reaction(Real-time PCR). The protein expressions of MEKK1, SEK1, JNK1 and AP-1 in tumor tissue were detected by immunofluorescence staining and Western blot.
Result
2
Compared with model group, the tumor weights of medium-dose and high-dose PNS groups were decreased significantly (
P
<
0.05). TUNEL staining showed that the number of apoptotic tumor cells increased with the rise of dosage of PNS (
P
<
0.05). The medium-dose and high-dose PNS groups showed a significant increase in the mRNA expressions of MEKK1, SEK1, JNK1 and AP-1 as well as the protein expressions of MEKK1, SEK1, JNK1 and AP-1 in tumor tissues (
P
<
0.05), with statistically significant differences (
P
<
0.05).
Conclusion
2
PNS could inhibit the tumor growth of breast cancer cell line 4T1 in tumor-bearing mice, which may be related to the activation of MEKK1/SEK1/JNK1/AP-1 signaling pathways.
GHONCHEH M , POURNAMDAR Z , SALEHINIYA H . Incidence and mortality and epidemiology of breast cancer in the world [J]. Asian Pac J Cancer Prev , 2016 , 17 ( S 3 ): 43 - 46 .
陈敬贤 , 林国珍 . 乳腺癌伴焦虑抑郁的中西医治疗研究 [J]. 吉林中医药 , 2012 , 32 ( 12 ): 1225 - 1227 .
张波 , 徐继宗 , 屈有山 , 等 . 自拟中药扶正散结方联合化疗对乳腺癌的治疗效果观察及对生存质量的影响 [J]. 中国中医药科技 , 2020 , 27 ( 1 ): 67 - 69 .
HUANG J W , DU Y Q , LI C J , et al . Neuroprotective triterpene saponins from the leaves of Panax notoginseng [J]. Nat Prod Res , 2019 , doi: 10.1080/14786419.2019.1677657 http://dx.doi.org/10.1080/14786419.2019.1677657 .
李青融 , 王子妤 . 三七总皂苷药理作用的研究进展 [J]. 湖南中医杂志 , 2017 , 33 ( 9 ): 216 - 218 .
HE N W , ZHAO Y , GUO L , et al . Antioxidant, antiproliferative, and pro-apoptotic activities of a saponin extract derived from the roots of Panax notoginseng (Burk.) F.H. Chen [J]. J Med Food , 2012 , 15 ( 4 ): 350 - 359 .
YANG Q B , WANG P W , CUI J G , et al . Panax notoginseng saponins attenuate lung cancer growth in part through modulating the level of Met/miR-222 axis [J]. J Ethnopharmacol , 2016 , doi: 10.1016/j.jep.2016.08.040 http://dx.doi.org/10.1016/j.jep.2016.08.040 .
WU Q , DENG J J , FAN D D , et al . Ginsenoside Rh4 induces apoptosis and autophagic cell death through activation of the ROS/JNK/p53 pathway in colorectal cancer cells [J]. Biochem Pharmacol , 2018 , doi: 10.1016/j.bcp.2017.12.004 http://dx.doi.org/10.1016/j.bcp.2017.12.004 .
刘玟君 , 陈勇 , 庞丹清 , 等 . 三七多糖研究进展 [J]. 辽宁中医药大学学报 , 2019 , 21 ( 7 ): 137 - 140 .
THULASI D K , LI X , ZHANG Y . MAP kinase signalling: interplays between plant PAMP- and effector-triggered immunity [J]. Cell Mol Life Sci , 2018 , 75 ( 16 ): 2981 - 2989 .
江一鸣 , 苏亮 , 徐钰 , 等 . 西黄丸调节MEKK1/SEK1通路抑制小鼠乳腺癌生长机制研究 [J]. 现代中药研究与实践 , 2019 , 33 ( 1 ): 24 - 29 .
董宏丹 . 苦参碱对荷4T1小鼠乳腺癌肿瘤模型JNK1/AP-1信号通路的影响 [J]. 辽宁中医药大学学报 , 2019 , 21 ( 11 ): 64 - 68 .
苏亮 , 江一鸣 , 李新叶 , 等 . 西黄丸调节JNK1/AP-1通路抑制荷4T1小鼠乳腺癌细胞生长 [J]. 药物评价研究 , 2018 , 41 ( 2 ): 189 - 193 .
章元沛 . 药理实验方法学 [M]. 2版 . 北京 : 人民卫生出版社 , 1996 , 238 .
王宁 , 刘硕 , 杨雷 , 等 . 2018全球癌症统计报告解读 [J]. 肿瘤综合治疗电子杂志 , 2019 , 5 ( 1 ): 87 - 97 .
曾召琼 , 易帆 , 李萍 , 等 . 中医药防治乳腺癌的研究进展 [J]. 中医药导报 , 2019 , 25 ( 23 ): 109 - 111 .
杨松 , 洪勇 . 三七总皂苷与乳腺癌治疗 [J]. 现代肿瘤医学 , 2018 , 26 ( 9 ): 1454 - 1457 .
杨泽娟 , 张宏 , 黄水才 , 等 . 三七总皂苷对大鼠乳腺癌变进程及miRNA-21表达影响的研究 [J]. 中医临床研究 , 2018 , 10 ( 13 ): 1 - 3 .
MATSUI K , XIAO S , FINE A , et al . Role of activator protein-1 in TCR-mediated regulation of the murine FasL promoter [J]. J Immunol , 2000 , 164 ( 6 ): 3002 - 3008 .
BLONSKA M , LIN X . CARMA1-mediated NF-kappaB and JNK activation in lymphocytes [J]. Immunol Rev , 2009 , 228 ( 1 ): 199 - 211 .
ENZLER T , CHANG X , FACCHINETTI V , et al . MEKK1 binds HECT E3 ligase Itch by its amino-terminal RING motif to regulate Th2 cytokine gene expression [J]. J Immunol , 2009 , 183 ( 6 ): 3831 - 3838 .
SUDDASON T , ANWAR S , CHARLAFTIS N , et al . T-cell-specific deletion of Map3k1 reveals the critical role for Mekk1 and Jnks in Cdkn1b-dependent proliferative expansion [J]. Cell Rep , 2016 , 14 ( 3 ): 449 - 457 .
OWEN G R , ACHILONU I , DIRR H W . High yield purification of JNK1 β 1 and activation by in vitro reconstitution of the MEKK1→MKK4→JNK MAPK phosphorylation cascade [J]. Protein Expr Purif , 2013 , 87 ( 2 ): 87 - 99 .
王一尧 , 任征远 , 焦战 , 等 . 西黄丸对肿瘤迁移微环境的影响 [J]. 中药药理与临床 , 2014 , 30 ( 4 ): 11 - 13 .
ZHOU Z W , LU X J , WANG J , et al . microRNA let-7c is essential for the anisomycin-elicited apoptosis in Jurkat T cells by linking JNK1/2 to AP-1/STAT1/STAT3 signaling [J]. Sci Rep , 2016 , doi: 10.1038/srep24434 http://dx.doi.org/10.1038/srep24434 .
BAUMANN S , HESS J , EICHHORST S T , et al . An unexpected role for FosB in activation-induced cell death of T cells [J]. Oncogene , 2003 , 22 ( 9 ): 1333 - 1339 .
鲁明骞 , 许新华 . MKK4与恶性肿瘤相关性的研究进展 [J]. 山东医药 , 2011 , 51 ( 19 ): 110 - 111 .
RAMAN M , CHEN W , COBB M H . Differential regulation and properties of MAPKs [J]. Oncogene , 2007 , 26 ( 22 ): 3100 - 3112 .
0
Views
18
下载量
4
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621